Arsenal Capital Partners has acquired ThermoSafe, enhancing its portfolio in temperature assurance technologies for healthcare logistics.

Target Information

ThermoSafe, based in Arlington Heights, Illinois, is a preeminent global provider of temperature assurance technologies dedicated to ensuring the safe and efficient transport of pharmaceuticals, biologics, vaccines, and other healthcare products. The company utilizes a network of vertically integrated operations to deliver a diverse range of industry-leading solutions, which include bio-based insulation materials and reusable technologies tailored for refrigerated, frozen, or controlled room temperature applications. Additionally, ThermoSafe operates ISC Labs®, offering customized design and testing services, innovative packaging technologies, and comprehensive qualification and validation support to comply with stringent regulatory standards.

With a commitment to sustainability and extensive experience, ThermoSafe collaborates with leading organizations in the healthcare and life sciences sectors to resolve cold chain challenges and enhance patient outcomes. Its product portfolio features advanced packaging solutions ranging from parcel shippers to bulk and reusable options that guarantee temperature stability throughout the transport process.

Industry Overview

The temperature assurance technologies industry is pivotal in the healthcare sector, particularly in the distribution of sensitive products like vaccines and biologics. The increasing demand for biopharmaceuticals, driven by advancements in medical research and public he